Amedeo's Top 20

Amedeo Smart

Independent Medical Education

10 August 2015

Multidisciplinary Journal Club

  1. .
    Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials.
    Lancet 2015.

  1. Lankisch PG, Apte M, Banks PA.
    Acute pancreatitis.
    Lancet 2015.

  2. .
    Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.
    Lancet 2015.

  3. Macle L, Khairy P, Weerasooriya R, Novak P, et al.
    Adenosine-guided pulmonary vein isolation for the treatment of paroxysmal atrial fibrillation: an international, multicentre, randomised superiority trial.
    Lancet 2015.

  4. Gara SK, Jia L, Merino MJ, Agarwal SK, et al.
    Germline HABP2 Mutation Causing Familial Nonmedullary Thyroid Cancer.
    N Engl J Med 2015;373:448-55.

  1. Goldberger JJ, Arora R, Green D, Greenland P, et al.
    Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate.
    Circulation 2015;132:278-91.

  2. Bruehl S.
    Complex regional pain syndrome.
    BMJ 2015;351:h2730.

  3. Verseveld M, de Graaf EJ, Verhoef C, van Meerten E, et al.
    Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery (CARTS study).
    Br J Surg 2015;102:853-60.

  4. Huttner FJ, Tenckhoff S, Jensen K, Uhlmann L, et al.
    Meta-analysis of reconstruction techniques after low anterior resection for rectal cancer.
    Br J Surg 2015;102:735-45.

  5. Nguyen TV, Seeman E.
    Osteoporosis: Treat and Live, or Let Die Twice More Likely.
    J Bone Miner Res 2015.

  1. Bekwelem W, Connolly SJ, Halperin JL, Adabag S, et al.
    Extracranial Systemic Embolic Events in Patients with Nonvalvular Atrial Fibrillation: Incidence, Risk Factors, and Outcomes.
    Circulation 2015.

  2. Chatterjee NA, Lubitz SA.
    Systemic Embolic Events (SEE) in Atrial Fibrillation: SEEing Embolic Risk More Clearly.
    Circulation 2015.

  3. Janz-Robinson EM, Badawi N, Walker K, Bajuk B, et al.
    Neurodevelopmental Outcomes of Premature Infants Treated for Patent Ductus Arteriosus: A Population-Based Cohort Study.
    J Pediatr 2015.

  4. Stoffel EM, Boland CR.
    Genetics and Genetic Testing in Hereditary Colorectal Cancer.
    Gastroenterology 2015.

  5. Josephs KA, Whitwell JL, Tosakulwong N, Weigand SD, et al.
    TDP-43 and pathological subtype of Alzheimer's disease impact clinical features.
    Ann Neurol 2015.

  1. Mutter RW, Frost MH, Hoskin TL, Johnson JL, et al.
    Breast cancer after prophylactic mastectomy (bilateral or contralateral prophylactic mastectomy), a clinical entity: presentation, management, and outcomes.
    Breast Cancer Res Treat 2015.

  2. Liu Z, Weaver J, de Papp A, Li Z, et al.
    Disparities in osteoporosis treatments.
    Osteoporos Int 2015.

  3. .
    Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial.
    Lancet 2015.

  4. Jebbink M, van Werkhoven E, Mandjes IA, Wesseling J, et al.
    The prognostic value of the neoadjuvant response index in triple-negative breast cancer: validation and comparison with pathological complete response as outcome measure.
    Breast Cancer Res Treat 2015.

  5. Nakhoul GN, Huang H, Arrigain S, Jolly SE, et al.
    Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease.
    Am J Nephrol 2015;41:456-463.


Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016